期刊文献+

重庆地区HCV基因亚型的分布状态 被引量:26

Distribution of hepatitis C virus subtypes in Chongqing: A preliminary study
暂未订购
导出
摘要 目的:探讨重庆地区丙型肝炎病毒(HCV)流行的基因亚型分布状态.方法:在77份抗HCV抗体和HCVRNA均阳性的血清标本中,分别提取HCVRNA,通过逆转录巢式PCR(RTnestedPCR)扩增C基因的羧基端至E1基因的氨基端长度为474bp的片段,测定其核苷酸序列,与GenBank中已知的HCV序列进行系谱分析,确定HCV基因亚型.结果:77份HCV感染者血清标本通过RTnestedPCR检测均获得阳性条带,该方法特异性和敏感性均较好.序列与系谱分析显示1b29例(38%),2a10例(13%),3a12例(16%),3b11例(14%),6a15例(19%),未见1a和2b型.结论:重庆地区HCV流行的基因亚型有1b,2a,3a,3b,6a共5种,1b为流行的主要基因亚型.2a,3a,3b和6a型均占相当比例,初步说明重庆地区HCV流行的基因亚型呈现多样性. AIM: To investigate the distribution status of hepatitis C virus subtypes in Chongqing region. METHODS: Serum specimens in this study were obtained from 77 patients whose anti-HCV and HCV RNA were positive. A reverse transcriptase PCR (RT- PCR) assay using conserved primers deduced from the core-envelope 1 (C-E1) region of the hepatitis C virus (HCV) genome was employed to amplify a 474- nucleotide-long fragment. Phylogenetic analysis of the C-E1 sequences was conducted by direct sequencing of the RT-PCR products and alignment with published HCV subtypes in GenBank. Subtypes of all the samples were determined by nucleotide sequencing followed by composition of a phylogenetic tree. RESULTS: All the electrophoretic fragments of HCV genotyping were positive. It was demonstrated that there were five different subtypes of HCV in Chongqing region, i.e. 1b, 29 cases (38%), 2a, 10 cases (13%), 3a, 12 cases (16%), 3b, 11 cases (14%), and 6a, 15 cases (19%). Two previously reported subtypes, 1a and 2b, were not found. CONCLUSION: The HCV subtypes found in Chongqing region are 1b, 2a, 3a, 3b and 6a. HCV subtype 1b, the main subtype, and subtypes 2a, 3a, 3b and 6a are of some proportions.
出处 《第四军医大学学报》 北大核心 2005年第14期1253-1256,共4页 Journal of the Fourth Military Medical University
基金 国家自然科学基金(30371663)
关键词 肝炎病毒 基因型 亚型 系谱分析 重庆 hepacivirus genotype subtype phylogenetic analysis Chongqing
  • 相关文献

参考文献9

  • 1Tatsunori N, Ling L, Pengbo L, et al. Viral gene sequences reveal the variable history of hepatitis C virus infection among countries [ J ]. J Infect Dis, 2004; 190 ( 15 ): 1098 - 1108.
  • 2Dale MN, Wang XH, Shruti HM, et al. Hepatitis C Virus (HCV)core antigen assay to detect ongoing HCV infection in Thai Injection drug users [J]. J Clin Microbiol, 2004; 42(4) :1631 - 1636.
  • 3Hall TA. BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT [ J ]. Nucl Acids Symp, 1999; 41: 95 -98.
  • 4Simmonds P. Viral heterogeneity of the hepatitis C virus[J]. J Hepatol, 1999;31 (1) :54 -60.
  • 5Pawlotsky JM. Molecular diagnosis of viral hepatitis [ J]. Gastroenterology, 2002 ;122(6) :1554 - 1568.
  • 6Nizar N. Clinical significance of hepatitis C virus genotypes [ J ].Clin Microbiol Rev, 2000; 13(2): 223 -235.
  • 7丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:732
  • 8刘斌,王宇明,谭朝霞.重庆地区69例丙型肝炎病毒感染基因分型研究[J].重庆医学,2002,31(3):174-175. 被引量:5
  • 9Doris BS,Teresa W, David LT, et al. Diagnosis, management, and treatment of hepatitis C [ J ]. Hepatology, 2004; 39 ( 4 ):1147 -1171.

二级参考文献18

  • 1朱思和 陈焕永 等.黑龙江地区丙型肝炎病毒的基因分型与临床关系的探讨[J].中华流行病学杂志,2000,21:204-204.
  • 2严福明,郝飞,顾长海.重型肝炎患者肝外组织丙型肝炎病毒特异性抗原的检测[J].重庆医学,1997,26(2):80-80. 被引量:1
  • 3Camma C, Bruno S, Schepis F, et al. Retreatment with interferon plus ribavirin of chronic hepatitis C non- responders to interferon monotherapy: a meta- analysis of individual patient data[ J ]. Gut, 2002,51:864-869.
  • 4Papatheodoridis GV, Papadimitropoulos VC, Hsdziyannis SJ. Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus- reated cirrhosis: a meta- analysis[J] .Aliment Pnarmaool Ther, 2001,15:689- 698.
  • 5Kjaergard LL, Krogsgaard K, Gluud C. Interfern alfa with or without ribavirin for chronic hepatitis C: systematic review of randonmised trials[J].BMJ, 2001,323:1151 - 1155.
  • 6Alberti A, Benvegnu L. Management of hepatitis[J] .J Hepatol, 2003,38(Suppl1): S1014 - S1 18.
  • 7Poynard T, MdHutchison J, Davis GL, et al. Impact of interferon alfa - 2b and ribavirin on progression of liver fibrosiis in patients with chronic hepatitis C[J].Hepatology, 2000,32:1131 - 1137.
  • 8Booth JCL, O' Grady J, Neuberger J. Clinical guidelines on the mangement of hepatitis C[J]. Gut, 2001, 49(Suppl I ): il - i12.
  • 9Chander G, Sulkowski MS, Jenckes MW, et al. Treatment of chronic hepatitis C: a systemic review[J]. Hepatology, 2002, 36(5 Suppl 1 ):S135 - S144.
  • 10Di Ciomm no V, Russo P, Rava L, etal. Interferon alpha in the treatment of chronic hepatitis C in children: a mmeta- analysis[J] .J Viral Hepat,2003,10:210 - 214.

共引文献733

同被引文献325

引证文献26

二级引证文献260

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部